Stimulation of progesterone, estradiol and cortisol in trophoblast tumor BeWo cells by glycodelin A N-glycans

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2101-2108

  Jeschke, Udo ^a   Richter, Dagmar Ulrike ^b   Möbius, Beate Maria ^b   Briese, Volker ^b   Mylonas, Ioannis ^a   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

BeWo; Cortisol; Estradriol; Glycodelin; hCG; Progesterone; Trophoblast

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HYDROCORTISONE; PLACENTA PROTEIN 14; PROGESTERONE;

CELL CULTURE; CELL STIMULATION; CHORIOCARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; TROPHOBLASTIC TUMOR;

CELL LINE, TUMOR; CHORIONIC GONADOTROPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FEMALE; GLYCOPROTEINS; HUMANS; HYDROCORTISONE; POLYSACCHARIDES; PREGNANCY; PREGNANCY PROTEINS; PROGESTERONE; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 34250711727     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M and Clark GF: Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem 270: 24116-24126, 1995.
2. Bohn H, Kraus W and Winckler W: New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl 4: 67-81, 1982.
3. Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF and Seppala M: Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod 2: 759-765, 1996.
4. Seppala M, Taylor RN, Koistinen H, Koistinen R and Milgrom E: Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23: 401-430, 2002.
5. Julkunen M, Koistinen R, Sjoberg J, Rutanen EM, Wahlstrom T and Seppala M: Secretory endometrium synthesizes placental protein 14. Endocrinology 118: 1782-1786, 1986.
6. Mylonas I, Speer R, Makovitzky J, Richter DU, Briese V, Jeschke U and Friese K: Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114: 405-411, 2000.
7. Julkunen M: Human decidua synthesizes placental protein 14 (PP14) in vitro. Acta Endocrinol (Copenh) 112: 271-277, 1986.
8. Julkunen M, Wahlstrom T, Seppala M, Koistinen R, Koskimies A, Stenman UH and Bohn H: Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch Androl 12 Suppl: 59-67, 1984.
9. Kamarainen M, Leivo I, Koistinen R, Julkunen M, Karvonen U, Rutanen EM and Seppala M: Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties. Am J Pathol 148: 1435-1443, 1996.
10. Kamarainen M, Riittinen L, Seppala M, Palotie A and Andersson LC: Progesterone-associated endometrial protein - a constitutive marker of human erythroid precursors. Blood 84: 467-473, 1994.
11. Pugachev KK, Tatarinov Iu S, Tsareva T, Shimbireva IB and Krivonosov SK: The cellular localization of the fertility alpha 2-microglobulin in tumors of the reproductive system. Vopr Onkol 36: 845-849, 1990.
12. Chatzaki E, Gallagher CJ, Iles RK, Ind TE, Nouri AM, Bax CM and Grudzinskas JG: Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. Br J Cancer 69: 1010-1014, 1994.
13. Hackenberg R, Loos S, Nia AH, Kunzmann R and Schulz KD: Expression of placental protein 14 by the new endometrial cancer cell line MFE-280 in vitro and by endometrial carcinomas in vivo. Anticancer Res 18: 1153-1158, 1998.
14. Horowitz IR, Cho C, Song M, Flowers LC, Santanam N, Parthasarathy S and Ramachandran S: Increased glycodelin levels in gynecological malignancies. Int J Gynecol Cancer 11: 173-179, 2001.
15. Kamarainen M, Halttunen M, Koistinen R, von Boguslawsky K, von Smitten K, Andersson LC and Seppala M: Expression of glycodelin in human breast and breast cancer. Int J Cancer 83: 738-742, 1999.
16. Jeschke U, Mylonas I, Kunert-Keil C, Dazert E, Shabani N, Werling M, Kuhn C, Janni W, Gerber B and Friese K: Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep 13: 413-419, 2005.
17. Pockley AG, Mowles EA, Stoker RJ, Westwood OM, Chapman MG and Bolton AE: Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14. J Reprod Immunol 13: 31-39, 1988.
18. Pockley AG and Bolton AE: Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes. Clin Exp Immunol 77: 252-256, 1989.
19. Pockley AG and Bolton AE: The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures. Immunology 69: 277-281, 1990.
20. Okamoto N, Uchida A, Takakura K, Kariya Y, Kanzaki H, Riittinen L, Koistinen R, Seppala M and Mori T: Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 26: 137-142, 1991.
21. Bolton AE, Pockley AG, Clough KJ, Mowles EA, Stoker RJ, Westwood OM and Chapman MG: Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet 1: 593-595, 1987.
22. Tomczak S, Briese V, Kunkel S and Muller H: Serum placental protein 14 (PP14) levels in patients with threatened abortion. Arch Gynecol Obstet 258: 165-169, 1996.
23. Grinnell BW, Hermann RB and Yan SB: Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 4: 221-225, 1994.
24. Jeschke U, Wang X, Briese V, Friese K and Stahn R: Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem Cell Biol 119: 345-354, 2003.
25. Julkunen M, Rutanen EM, Koskimies A, Ranta T, Bohn H and Seppala M: Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 92: 1145-1151, 1985.
26. Seppala M, Taylor RN, Koistinen H, Koistinen R and Milgrom E: Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23: 401-430, 2002.
27. Jeschke U, Richter DU, Walzel H, Bergemann C, Mylonas I, Sharma S, Keil C, Briese V and Friese K: Stimulation of hCG and inhibition of hPL in isolated human trophoblast cells in vitro by glycodelin A. Arch Gynecol Obstet 268: 162-167, 2003.
28. Hokke CH and van den Eijnden DH: Enzyme-assisted synthesis of Asn-linked diantennary oligosaccharides occurring on glycodelin A. Carbohydr Res 305: 463-468, 1997.
29. Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, Mylonas I and Friese K: Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J Perinat Med 33: 212-218, 2005.
30. Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR and Verrill HL: Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 47: 308-315, 2001.
31. Jeschke U, Mylonas I, Richter DU, Streu A, Muller H, Briese V and Friese K: Human amniotic fluid glycoproteins expressing sialyl Lewis carbohydrate antigens stimulate progesterone production in human trophoblasts in vitro. Gynecol Obstet Invest 58: 207-211, 2004.
32. Jeschke U, Richter DU, Briese V, Mylonas I and Friese K: Stimulation of HCG, estrogen and progesterone production in isolated trophoblast cells by glycodelin a or its N-glycans. Z Geburtshilfe Neonatol 209: 59-64, 2005.
33. Hocker I, Briese V, Richter DU, Mylonas I, Friese K and Jeschke U: Investigations on regulation of CRH, ACTH and cortisol in trophoblast cells in vitro. Zentralbl Gynakol 125: 409-414, 2003.
34. Bahn RS, Worsham A, Speeg KV Jr, Ascoli M and Rabin D: Characterization of steroid production in cultured human choriocarcinoma cells. J Clin Endocrinol Metab 52: 447-450, 1981.
35. Stites DP and Siiteri PK: Steroids as immunosuppressants in pregnancy. Immunol Rev 75: 117-138, 1983.
36. Pepe GJ and Albrecht ED: Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 16: 608-648, 1995.
37. Jeschke U, Karsten U, Wiest I, Schulze S, Kuhn C, Friese K and Walzel H: Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem Cell Biol 126: 437-444, 2006.
38. Wiest I, Seliger C, Walzel H, Friese K and Jeschke U: Induction of apoptosis in human breast cancer and trophoblast tumor cells by galectin-1. Anticancer Res 25: 1575-1580, 2005.
39. Renkonen J, Paavonen T and Renkonen R: Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 74: 296-300, 1997.
40. Jeschke U, Reimer T, Bergemann C, Wiest I, Schulze S, Friese K and Walzel H: Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1. Histochem Cell Biol, 2004.
41. Bukovsky A, Cekanova M, Caudle MR, Wimalasena J, Foster JS, Henley DC and Elder RF: Expression and localization of estrogen receptor-alpha protein in normal and abnormal term placentae and stimulation of trophoblast differentiation by estradiol. Reprod Biol Endocrinol 1: 13, 2003.
42. Jiang SW, Lloyd RV, Jin L and Eberhardt NL: Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells. DNA Cell Biol 16: 969-977, 1997.
43. Anderson NG, Curet LB and Colas AE: Changes in C21-steroid metabolism by ovine placentas during cortisol administration. Biol Reprod 18: 652-657, 1978.
44. McMullen S, Osgerby JC, Thurston LM, Gadd TS, Wood PJ, Wathes DC and Michael AE: Alterations in placental 11 beta-hydroxysteroid dehydrogenase (11 betaHSD) activities and fetal cortisol:cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation in ewes. Reproduction 127: 717-25, 2004.
45. Sun K, Yang K and Challis JR: Glucocorticoid actions and metabolism in pregnancy: implications for placental function and fetal cardiovascular activity. Placenta 19: 353-360, 1998.
46. McMillen IC, Warnes KE, Adams MB, Robinson JS, Owens JA and Coulter CL: Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus. Endocrinology 141: 539-543, 2000.
47. Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R and Akhurst R: Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum Reprod 3: 909-914, 1988.
48. Jameson JL and Hollenberg AN: Regulation of chorionic gonadotropin gene expression. Endocr Rev 14: 203-21, 1993.
49. Johnson W, Albanese C, Handwerger S, Williams T, Pestell RG and Jameson JL: Regulation of the human chorionic gonadotropin alpha- and beta-subunit promoters by AP-2. J Biol Chem 272: 15405-15412, 1997.
50. Pestell RG, Hollenberg AN, Albanese C and Jameson JL: c-Jun represses transcription of the human chorionic gonadotropin alpha and beta genes through distinct types of CREs. J Biol Chem 269: 31090-31096, 1994.
51. Mochizuki M, Maruo T, Matsuo H, Samoto T and Ishihara N: Biology of human trophoblast. Int J Gynaecol Obstet 60: S21-S28, 1998.
52. Ulloa-Aguirre A, Maldonado A, Damian-Matsumura P and Timossi C: Endocrine regulation of gonadotropin glycosylation. Arch Med Res 32: 520-532, 2001.
53. Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, Cohen M, Kelly A, Schlatterer J and O'Connor JF: Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol 172: 497-506, 2002.
54. Maston GA and Ruvolo M: Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection. Mol Biol Evol 19: 320-335, 2002.
55. Albanese C, Kay TW, Troccoli NM and Jameson JL: Novel cyclic adenosine 3′,5′-monophosphate response element in the human chorionic gonadotropin beta-subunit gene. Mol Endocrinol 5: 693-702, 1991.
56. Hollenberg AN, Pestell RG, Albanese C, Boers ME and Jameson JL: Multiple promoter elements in the human chorionic gonadotropin beta subunit genes distinguish their expression from the luteinizing hormone beta gene. Mol Cell Endocrinol 106: 111-119, 1994.
57. Seki H, Zosmer A, Elder MG and Sullivan MH: The regulation of progesterone and hCG production from placental cells by interleukin-1beta. Biochim Biophys Acta 1336: 342-348, 1997.
58. Kovalevskaya G, Genbacev O, Fisher SJ, Caceres E and O'Connor JF: Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG. Mol Cell Endocrinol 194: 147-155, 2002.
59. Islami D, Chardonnens D, Campana A and Bischof P: Comparison of the effects of GnRH-I and GnRH-II on HCG synthesis and secretion by first trimester trophoblast. Mol Hum Reprod 7: 3-9, 2001.
60. Jablonka-Shariff A, Garcia-Campayo V and Boime I: Evolution of lutropin to chorionic gonadotropin generates a specific routing signal for apical release in vivo. J Biol Chem 277: 879-882, 2002.
61. Birken S, Krichevsky A, O'Connor J, Schlatterer J, Cole L, Kardana A and Canfield R: Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 10: 137-144, 1999.
62. Tarrade A, Schoonjans K, Guibourdenche J, Bidart JM, Vidaud M, Auwerx J, Rochette-Egly C and Evain-Brion D: PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 142: 4504-4514, 2001.
63. Cameo P, Bischof P and Calvo JC: Effect of leptin on progesterone, human chorionic gonadotropin, and interleukin-6 secretion by human term trophoblast cells in culture. Biol Reprod 68: 472-477, 2003.
64. Flower DR: Beyond the superfamily: the lipocalin receptors. Biochim Biophys Acta 1482: 327-336, 2000.
65. Jeschke U, Briese V, Richter D, Kunkel S, Walzel H and Friese K: Neue Ergebnisse zur hCG-Regulation in der Plazenta. Geburtshilfe Frauenheilkd 57: 681-684, 1997.
66. Bergemann C, Reimer T, Muller H, Hosel A, Briese V, Friese K and Jeschke U: Stimulation of hCG protein and mRNA levels in trophoblast tumour cells Jeg3 and BeWo by glycodelin A. Anticancer Res 23: 1107-13, 2003.
67. Jeschke U, Briese V, Richter D and Kunkel S: Stimulation trials of trophoblast cells in vitro using PP14. Z Geburtshilfe Neonatol 200: 199-201, 1996.
68. Jeschke U, Gundel G, Muller H, Richter DU, Streu A, Briese V, Mylonas I, Friese K and Unverzagt C: N-glycans of human amniotic fluid transferrin stimulate progesterone production in human first trimester trophoblast cells in vitro. J Perinat Med 32: 248-253, 2004.
69. Jeschke U, Richter DU, Reimer T, Bergemann C, Briese V, Karsten U, Mylonas I, Kupka MS, Wiest I and Friese K: Glycodelin A and differentiation of first trimester trophoblast cells in vitro. Arch Gynecol Obstet 272: 151-159, 2005.